Area of research
Pulmonary and Respiratory Medicine · Immunology
Research interest
Research interests include Vasculitis and related conditions, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Renal Diseases and Glomerulopathies, and Cell Adhesion Molecules Research.
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody–induced crescentic glomerulonephritis
Flow-Cytometric Quantification of Urine Kidney Epithelial Cells Specifically Reflects Tubular Damage in Acute Kidney Diseases
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange
Urinary CD4+ T Cells Predict Renal Relapse in ANCA-Associated Vasculitis
β2-integrins control HIF1α activation in human neutrophils
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
Daratumumab for the treatment of refractory ANCA-associated vasculitis
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis
Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation
First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine – case report
Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Therapeutic targeting of cathepsin C: from pathophysiology to treatment